AMN Healthcare Services

NYSE
AMN
Stock
Yield per half year: -20.94%
Dividend yield: 0%
Sector: Healthcare

Company Analysis AMN Healthcare Services

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Price (20.77 $) is less than fair price (42.74 $)
  • The company's current efficiency (ROE=-19.11%) is higher than the sector average (ROE=-83.36%)

Disadvantages

  • Dividends (0%) are below the sector average (1.26%).
  • The stock's return over the last year (-63.07%) is lower than the sector average (-34.84%).
  • Current debt level 45.44% has increased over 5 years from 31.95%.

Similar companies

Allergan

UnitedHealth Group

Bristol-Myers

Humana

2. Share price and performance

2.1. Share price

2.3. Market efficiency

AMN Healthcare Services Healthcare Index
7 days -7.4% -6.9% 0.7%
90 days -22.7% -34.2% 7.6%
1 year -63.1% -34.8% 11.7%

AMN vs Sector: AMN Healthcare Services has significantly underperformed the "Healthcare" sector by -28.23% over the past year.

AMN vs Market: AMN Healthcare Services has significantly underperformed the market by -74.75% over the past year.

Stable price: AMN is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: AMN with weekly volatility of -1.21% over the past year.

3. Summary of the report

3.1. General

P/E: 13.97
P/S: 0.3047

3.2. Revenue

EPS -3.85
ROE -19.11%
ROA -5.5%
ROIC 22.41%
Ebitda margin 2.48%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Below fair price: The current price (20.77 $) is lower than the fair price (42.74 $).

Price significantly below the fair price: The current price (20.77 $) is 105.8% lower than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (13.97) is lower than that of the sector as a whole (53.14).

P/E vs Market: The company's P/E (13.97) is lower than that of the market as a whole (62.2).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (1.29) is lower than that of the sector as a whole (10.88).

P/BV vs Market: The company's P/BV (1.29) is lower than that of the market as a whole (20.84).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (0.3047) is lower than that of the sector as a whole (4.06).

P/S vs Market: The company's P/S indicator (0.3047) is lower than that of the market as a whole (16.02).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (27.02) is higher than that of the sector as a whole (16.98).

EV/Ebitda vs Market: The company's EV/Ebitda (27.02) is lower than that of the market as a whole (27.16).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -61.4% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-61.4%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-10.32%).

5.4. ROE

ROE vs Sector: The company's ROE (-19.11%) is higher than that of the sector as a whole (-83.36%).

ROE vs Market: The company's ROE (-19.11%) is lower than that of the market as a whole (43.08%).

5.5. ROA

ROA vs Sector: The company's ROA (-5.5%) is lower than that of the sector as a whole (6.41%).

ROA vs Market: The company's ROA (-5.5%) is lower than that of the market as a whole (23.27%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (22.41%) is higher than that of the sector as a whole (15.68%).

ROIC vs Market: The company's ROIC (22.41%) is higher than that of the market as a whole (9.29%).

6. Finance

6.1. Assets and debt

Debt level: (45.44%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 31.95% to 45.44%.

Excess of debt: The debt is not covered by net income, percentage -746.91%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '1.26%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum AMN Healthcare Services

9.3. Comments